CMAC Response to Covid-19

In keeping with the latest government advice, CMAC are now advancing our plans to resume lab activities in the coming weeks. We look forward to keeping our partners informed as we progress and adapt to these changes to keep everyone safe and well and resume our collaborative research, training and translation programmes. Find out how CMAC are responding to the global Covid-19 pandemic.

Find out more
Business Case Insights for Continuous Manufacturing

CMAC and PwC are delighted to share ‘The Business Case Insights for Continuous Manufacturing’. This joint document, with input from industrial partners, seeks to review key considerations for building a successful business case for the industrial adoption of innovative Continuous Manufacturing (CM) technologies.

Find out more

CMAC

CMAC is a world-class international hub for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future.

Find out more

Our Vision

CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made. The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 30 PhD students, as well as an experienced support team.

CMAC

  • conducts world class research in continuous manufacturing and advanced crystallisation;
  • conducts fundamental research;
  • develops new solutions to company specific problems;
  • delivers measurable successes that are of real benefit to society;
  • creates commercial opportunities for start-ups and major global companies;
  • produces a talent pipeline of highly skilled multi-disciplinary staff;
  • influences policy, government, and regulators;
  • understands and integrates with the broader supply chain context
  • collaborates with world class business and academia on an international basis.


 
Research

Industrially relevant research delivered by a multidisciplinary and collaborative academic team

Find out more
Award Winning Facility

Comprehensive suite of continuous processing, process analysis, and characterisation equipment housed in the Technology and Innovation Centre at Strathclyde

Find out more
Training & Skills

A vibrant world-class, multi-disciplinary PhD & MSc training programmes that will equip graduates with leading edge skills in pioneering continuous processes

Find out more
Translation to Industry

The demand-led manufacturing research scope of the Centre was co-created with our industry partners

Find out more

Events

CMAC - Funding Manager
CMAC are seeking a funding manager who will be responsible for the development of high quality research funding proposals and grant applications, working with key academic and industrial partners s to develop priority research collaboration opportunities and


diversify the research and enterprise income of CMAC. The post-holder will operate with a high degree of autonomy,


providing expert advice and knowledge of sectors/markets to identify new opportunities for collaboration and exploitation of


research capability and facilities. .... more

PhD Vacancy: Plant-wide dynamic mathematical modelling and optimisation of integrated continuous pharmaceutical manufacturing processes
PhD Vacancy: Plant-wide dynamic mathematical modelling and optimisation of integrated continuous pharmaceutical manufacturing processes.... more

Automated Synthesis Forum
At TIC, University of Strathclyde.... more

News

Business Case Insights for Continuous Manufacturing
CMAC and PwC are delighted to share ‘The Business Case Insights for Continuous Manufacturing’. This joint document, with input from industrial partners, seeks to review key considerations for building a successful business case for the industrial adoption of innovative Continuous Manufacturing (CM) technologies..... more

CPI launches the SCOUT project to benefit chemical and biochemical SMEs across Scotland
CPI, an independent technology innovation centre and founding member of the UK Government’s High Value Manufacturing Catapult, has today announced the launch of SCOUT, a project to target a breadth of Scottish SMEs working in the high value chemical and biochemical supply chains. The project will leverage technology within CPI and its partner organisations to accelerate and de-risk the growth of Scottish SMEs – including those underserved and remote – by enabling new partnerships and increased technology adoption.



The SCOUT project, which will run over the next three years, will be led by CPI’s Medicines Manufacturing Innovation Centre and is being launched in collaboration with CMAC Future Manufacturing Research Hub and the Industrial Biotechnology Innovation Centre (IBioIC). It aims to serve Scottish SMEs through a three-pronged approach of innovation clinics (currently planned to start in late 2020), Innovation Integrator assessments and deep technical consultancy. The £882k Scottish Outreach (SCOUT) project is jointly funded by the European Regional Development Fund (managed by Scottish Enterprise) CPI, CMAC and IBioIC..... more

CMAC Future Manufacturing Research Hub Operations during COVID-19
In response to the Covid-19 outbreak and following advice from the WHO, the UK and Scottish Governments, the University of Strathclyde has taken the decision to restrict highly populated areas in the interest of student and staff safety. Therefore CMAC has closed all laboratory and office areas.​.... more